Developer of a workflow able to reveal potential target proteins for prognosis, diagnosis, and therapy in blood plasma.
By conducting an in-depth N-glycoproteomic analysis of human blood plasma proteins, this workflow has demonstrated to be able to detect blood plasma proteins coming from tissue-leakage. Those proteins are four orders of magnitude less abundant than the typical glycoproteins observed by the direct analysis of blood plasma. The workflow will be applied to blood plasma samples derived from cohorts of clinical interest. This will help to discover alterations in the N-glycosylation related to specific physiological conditions on a more diverse range of blood plasma proteins.
Degree in Biochemical Engineering at the National Technological Institute of Mexico, campus Tepic. During the undergraduate program, she followed three research internships in the fields of Protein Evolution, Protein Engineering and Parasite Infection.
Degree in Master of Biochemical Sciences at the Institute of Biotechnology from the National Autonomous University of Mexico. The research was focused on the understanding of the effect of redox potential in the sialylation of a monoclonal antibody. This project achieved the generation of a baculovirus capable to express a redox potential sensor protein in the mammalian cell’s Golgi Complex.
Early stage researcher in a multisectoral and interdisciplinary Ph.D. program since February 2018 in Magdeburg, Germany. Ph.D student at the Max Planck Institute for Dynamics of Complex Technical Systems, and glyXera GmbH, company specialized in High-Performance Glycoanalysis.
Personally interested in sustainable development, nature, ethnology, and philosophy.
Would you like to know more? Please visit: MPI-Human Blood Plasma N-Glycoproteomics
“We are what we do for changing what we are”. -Eduardo Galeano.